Stolp HB and Solito E (2024). Developmental priming of early cerebrovascular ageing: Implications across a lifetime. Wiley  International Journal of Geriatric Psychiatry  vol. 39, (4)  

Fu H, Vuononvirta J, Fanti S, Bonacina F, D’Amati A, Wang G, Poobalasingam T, Fankhaenel M, Lucchesi D, Coleby R, Tarussio D, Thorens B, Hearnden RJ, Longhi M, Grevitt P, Madeeha S, Egle S, Godinho S, Bombardieri M, Smith D, Cooper D, Asif I, Rathmell JC, Schaefer S, Morales V, Bianchi K, Norata GD and Marelli-Berg F (2023). The Glucose Transporter 2 regulates CD8+ T cell function via environment sensing., Editors: Figliuolo ML. Nature Research  Nature Metabolism   

Cortese P, Amato F, Davino A, De Franchis R, Esposito S, Zollo I, Di Domenico M, Solito E, Zarrilli F, Gentile L, Cernera G and Castaldo G (2023). The Immune Response to SARS-CoV-2 Vaccine in a Cohort of Family Pediatricians from Southern Italy. MDPI  Cells  vol. 12, (11)  

De Vitis C, Battaglia AM, Pallocca M, Santamaria G, Mimmi MC, Sacco A, De Nicola F, Gaspari M, Salvati V, Ascenzi F, Bruschini S, Esposito A, Ricci G, Sperandio E, Massacci A, Prestagiacomo LE, Vecchione A, Ricci A, Sciacchitano S, Salerno G, French D, Aversa I, Cereda C, Fanciulli M, Chiaradonna F, Solito E, Cuda G, Costanzo F, Ciliberto G and Mancini R (2023). ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis. Springer Nature  Journal of Experimental & Clinical Cancer Research  vol. 42, (1)  

Wickstead ES, Solito E and Mcarthur S (2022). Promiscuous Receptors and Neuroinflammation: The Formyl Peptide Class. MDPI  Life  vol. 12, (12)  

Fanti S, Stephenson E, Rocha-Vieira E, Protonotarios A, Kanoni S, Shahaj E, Longhi MP, Vyas VS, Dyer C, Pontarini E, Asimaki A, Bueno-Beti C, De Gaspari M, Rizzo S, Basso C, Bombardieri M, Coe D, Wang G, Harding D, Gallagher I, Solito E, Elliott P, Heymans S, Sikking M, Savvatis K, Mohiddin SA and Marelli-Berg FM (2022). Circulating c-Met–Expressing Memory T Cells Define Cardiac Autoimmunity. Wolters Kluwer  Circulation  vol. 146, (25) 1930-1945.  

Robbins JP and Solito E (2022). Does Neuroinflammation Underlie the Cognitive Changes Observed With Dietary Interventions? Frontiers  Frontiers in Neuroscience  vol. 16,  

Chee SEJ and Solito E (2021). The Impact of Ageing on the CNS Immune Response in Alzheimer’s Disease. Frontiers  Frontiers in Immunology  vol. 12,  

Mohammad S, Zoubi SA, Collotta D, Krieg N, Wissuwa B, Alves GF, Purvis GSD, Norata GD, Baragetti A, Catapano AL, Solito E, Zechendorf E, Schürholz T, Correa-Vargas W, Brandenburg K, Coldewey SM, Collino M, Yaqoob MM, Martin L and Thiemermann C (2021). A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice. Frontiers in Immunology  vol. 12, 701275-701275.  

Reis M, Watts H, Mota B, Yanez-lopez M, Donat C, Baxan N, Pickering J, Chaw T, Annika S, Brinda G, Aleksynas R, Habelleiras-Hervas L, Iqbal S, Romero-Molina C, Hernandez-Mir G, d'Amati A, Reutelingsperger C, Goldfinger M, Gentleman S, Leuven F, Sastre M and Solito E (2021). Annexin-A1 restores cerebrovascular integrity concomitant with reduced amyloid-β and tau pathology. Oxford University Press (OUP)  Brain: a journal of neurology   

Solito E, Marelli-Berg F, Fanti S, Cheung K, Mauro C, Wang G, Nair A, Fu H, Angeletti S, Spoto S, Fogolari M, Romano F, Aksentijevic D, Liu W, Li B, Cheng L, YANG LW, Juho V, Thanushiyan P, Smith D and Ciccozzi M (2020). Preservation of microvascular barrier function requires CD31 receptor-induced metabolic reprogramming. Nature Research (part of Springer Nature)  Nature Communications  vol. 11,  

Callender L, Carroll E, BOBER E, Akbar A, Solito E and Henson S (2019). Mitochondrial mass governs the extent of human T cell senescence. John Wiley & Sons Ltd  Aging Cell  vol. 19, (2)  

Solito E, Montague-Cardoso K, Pitcher T, Chisolm K, Salera G, Lindstrom E, Hewitt E and Malcangio M (2019). Changes in vascular permeability in the spinal cord contribute to chemotherapy- induced neuropathic pain. Elsevier  Brain Behaviour and Immunity   

Solito E, Zub E, Canet G, Garbelli R, Blaquiere M, Rossini L, Pastori C, Sheikh M, Reutelingsperger C, Klement W, de Bock F, Audinat E, Givalois L and Marchi N (2019). The GR-ANXA1 pathway is a pathological player and a candidate target in epilepsy., Editors: Weksler B. Federation of American Society of Experimental Biology  The FASEB Journal   

Solito E, Colamatteo A, Maggioli E, Azevedo Loiola R, Sheikh M, Cali G, Bruzzese D, Maniscalco T, Centonze D, Buttari F, Lanzillo R, Perna F, Zuccarelli B, Mottola M, Cassano S, Galgani M and De Rosa V (2019). Reduced Annexin A1 expression associates with disease severity and inflammation in multiple sclerosis patients. American Association of Immunologists  Journal of Immunology   

da Rocha GHO, Loiola RA, Pantaleão LDN, Reutelingsperger C, Solito E and Farsky SHP (2019). Control of expression and activity of peroxisome proliferated-activated receptor γ by Annexin A1 on microglia during efferocytosis. Wiley  Cell Biochemistry and Function   

SOLITO EGLE, PURVIS G and THIEMERMANN C (2019). Annexin-A1: therapeutic potential in microvascular disease. Frontiers Media  Frontiers in Immunology   

Purvis GSD, Collino M, Loiola RA, Baragetti A, Chiazza F, Brovelli M, Sheikh MH, Collotta D, Cento A, Mastrocola R, Aragno M, Cutrin JC, Reutelingsperger C, Grigore L, Catapano AL, Yaqoob MM, Norata GD, Solito E and Thiemermann C (2019). Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes. Frontiers  Frontiers in Immunology  vol. 10,  

SOLITO E (2018). Connections of Annexin A1 and Translocator Protein-18 KDa on Toll Like Receptor Stimulated BV-2 Cells. Exp Cell Res.   

SOLITO E and SHEIKH M (2018). Annexin A1: Uncovering the Many Talents of an Old Protein. MDPI AG  International Journal of Molecular Sciences  vol. 19,  

S. D. Purvis G and Solito E (2018). Is AnnexinA1 The Miracle Drug For Diabetes? Science Trends  Science Trends   

Purvis GSD, Chiazza F, Chen J, Loiola RA, Martin L, Fountoulakis N, Gnudi L, Collino M, Thiemermann C and Solito E (2017). Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes. Springer Verlag  Diabetologia   

Lima KM, Vago JP, Caux TR, Negreiros-Lima GL, Sugimoto MA, Tavares LP, Arribada RG, Carmo AAF, Galvão I, Costa BRC, Soriani FM, Pinho V, Solito E, Perretti M, Teixeira MM and Sousa LP (2017). The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1. Elsevier  Journal of Biological Chemistry  vol. 292, (33) 13758-13773.  

Sinniah A, Yazid S, Perretti M, Solito E and Flower RJ (2016). The role of the Annexin-A1/FPR2 system in the regulation of mast cell degranulation provoked by compound 48/80 and in the inhibitory action of nedocromil. Elsevier  International Immunopharmacology  vol. 32, 87-95.  

Yazid S, Gardner PJ, Carvalho L, Chu CJ, Flower RJ, Solito E, Lee RWJ, Ali RR and Dick AD (2015). Annexin-A1 restricts Th17 cells and attenuates the severity of autoimmune disease. Elsevier  Journal of Autoimmunity  vol. 58, 1-11.  

Mauro C, De Rosa V, Marelli-Berg F and Solito E (2015). Metabolic Syndrome and the Immunological Affair with the Blood–Brain Barrier. Frontiers  Frontiers in Immunology  vol. 5,  

Queiroz CJDS, Nakata CMDAG, Solito E and Damazo AS (2014). Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer. Infect Agent Cancer  vol. 9,  

dos Santos Queiroz CJ, de Amorim Gomes Nakata CM, Solito E and Damazo AS (2014). Relationship between HPV and biomarkers annexin A1 and P53 in oropharyngeal cancer. Elsevier  Pathology  vol. 46,  

Girol AP, Mimura KKO, Drewes CC, Bolonheis SM, Solito E, Farsky SHP, Gil CD and Oliani SM (2013). Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro. J Immunol  vol. 190, (11) 5689-5701.  

Cristante E, McArthur S, Mauro C, Maggioli E, Romero IA, Wylezinska-Arridge M, Couraud PO, Lopez-Tremoleda J, Christian HC, Weksler BB, Malaspina A and Solito E (2013). Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci U S A  vol. 110, (3) 832-841.  

Yazid S, Sinniah A, Solito E, Calder V and Flower RJ (2013). Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1. PLoS One  vol. 8, (3)  

Mehet DK, Philip J, Solito E, Buckingham JC and John CD (2012). Evidence from in vitro and in vivo studies showing that nuclear factor-κB within the pituitary folliculostellate cells and corticotrophs regulates adrenocorticotrophic hormone secretion in experimental endotoxaemia. J Neuroendocrinol  vol. 24, (6) 862-873.  

Solito E and Sastre M (2012). Microglia function in Alzheimer's disease. Front Pharmacol  vol. 3,  

McArthur S, Cristante E, Paterno M, Christian H, Roncaroli F, Gillies GE and Solito E (2010). Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia. J Immunol  vol. 185, (10) 6317-6328.  

Yazid S, Leoni G, Getting SJ, Cooper D, Solito E, Perretti M and Flower RJ (2010). Antiallergic cromones inhibit neutrophil recruitment onto vascular endothelium via annexin-A1 mobilization. Arterioscler Thromb Vasc Biol  vol. 30, (9) 1718-1724.  

Yazid S, Ayoub SS, Solito E, McArthur S, Vo P, Dufton N and Flower RJ (2010). Anti-allergic drugs and the Annexin-A1 system. Pharmacol Rep  vol. 62, (3) 511-517.  

McArthur S, Yazid S, Christian H, Sirha R, Flower R, Buckingham J and Solito E (2009). Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization. FASEB J  vol. 23, (11) 4000-4010.  

Yazid S, Solito E, Christian H, McArthur S, Goulding N and Flower R (2009). Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1. Biochem Pharmacol  vol. 77, (12) 1814-1826.  

Yazid S, Solito E, Christian H, Goulding N and Flower R (2008). Further studies on the rapid glucocorticoid effects in the U937 monocytic cell line and its potentiation by cromoglycate-like drugs. FUND CLIN PHARMACOL  vol. 22, 47-47.  

McArthur S, Prasongchean W, Gillies G and Solito E (2008). A critical role for the anti-inflammatory protein annexin A1 in microglial phagocytosis. FUND CLIN PHARMACOL  vol. 22, 23-23.  

Damazo AS, Flower RJ, Solito E and Oliani SM (2008). Annexin-A1 gene expression during liver development and post-translation modification after experimental endotoxemia. INFLAMM RES  vol. 57, (3) 97-103.  

Hu NJ, Bradshaw J, Lauter H, Buckingham J, Solito E and Hofmann A (2008). Membrane-induced folding and structure of membrane-bound annexin A1 N-terminal peptides: Implications for annexin-induced membrane aggregation. BIOPHYS J  vol. 94, (5) 1773-1781.  

Solito E, McArthur S, Christian H, Gavins F, Buckingham JC and Gillies GE (2008). Annexin A1 in the brain--undiscovered roles? Trends Pharmacol Sci  vol. 29, (3) 135-142.  

John CD, Sahni V, Mehet D, Morris JF, Christian HC, Perretti M, Flower RJ, Solito E and Buckingham JC (2007). Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides. FASEB J  vol. 21, (4) 1037-1046.  

Warne JP, John CD, Christian HC, Morris JF, Flower RJ, Sugden D, Solito E, Gillies GE and Buckingham JC (2006). Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue. AM J PHYSIOL-ENDOC M  vol. 291, (6) E1264-E1273.  

Kamal AM, Hayhoe RPG, Paramasivam A, Cooper D, Flower RJ, Solito E and Perretti M (2006). Antiflammin-2 activates the human formyl-peptide receptor like 1. ScientificWorldJournal  vol. 6, 1375-1384.  

Buckingham J, John C, Solito E, Flower R, Christian H and Morris J (2006). Annexin 1: a mediator of glucocorticoid action at the neuroendocrine-immune interface. ACTA PHARMACOL SIN  vol. 27, 1-1.  

FLOWER RJ, Buckingham JC, Tierney T, Festa M, Christian HC, Solito E and Mulla A (2006). Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. Faseb J  vol. 20, (9) 1498-1500.  

Solito E, Christian HC, Festa M, Mulla A, Tierney T, Flower RJ and Buckingham JC (2006). Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J  vol. 20, (9) 1498-1500.  

Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E and Parente L (2006). Down-regulation of annexin-1 expression in thyroid cancers is associated with tumour aggressiveness. ACTA PHARMACOL SIN  vol. 27, 65-65.  

Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E and Parente L (2006). Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol Ther  vol. 5, (6) 643-647.  

Rodrigues-Lisoni FC, Mehet DK, Peitl P, John CD, da Silva WA, Tajara E, Buckingham JC and Solito E (2006). In vitro and in vivo studies on CCR10 regulation by Annexin A1 (vol 580, pg 1431, 2006). FEBS LETT  vol. 580, (7) 1908-1908.  

Hayhoe RPG, Kamal AM, Solito E, Flower RJ, Cooper D and Perretti M (2006). Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. BLOOD  vol. 107, (5) 2123-2130.  

Rodrigues-Lisoni FC, Mehet DK, Peitl P, John CD, da Silva Júnior WA, Tajara E, Buckingham JC and Solito E (2006). In vitro and in vivo studies on CCR10 regulation by Annexin A1. FEBS Lett  vol. 580, (5) 1431-1438.  

Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E and Parente L (2005). Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells. Cell Death Differ  vol. 12, (10) 1358-1360.  

Rodrigues-Lisoni FC, Oliani S, Buckingham J, Solito E and Tajara EH (2005). Annexin A1: From gene organization to physiology. Annexins  vol. 2, (2)  

Mulla A, Leroux C, Solito E and Buckingham JC (2005). Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function. J Clin Endocrinol Metab  vol. 90, (1) 557-562.  

Perretti M and Solito E (2004). Annexin 1 and neutrophil apoptosis. BIOCHEMICAL SOCIETY TRANSACTIONS  vol. 32, 507-510.  

John CD, Christian HC, Morris JF, Flower RJ, Solito E and Buckingham JC (2004). Annexin 1 and the regulation of endocrine function. TRENDS ENDOCRIN MET  vol. 15, (3) 103-109.  

Parente L and Solito E (2004). Annexin 1: more than an anti-phospholipase protein. Inflamm Res  vol. 53, (4) 125-132.  

Mulla A, Christian HC, Solito E, Mendoza N, Morris JF and Buckingham JC (2004). Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin Endocrinol (Oxf)  vol. 60, (1) 107-119.  

Tierney T, Christian HC, Morris JF, Solito E and Buckingham JC (2003). Evidence from studies on co-cultures of TtT/GF and AtT20 cells that Annexin 1 acts as a paracrine or juxtacrine mediator of the early inhibitory effects of glucocorticoids on ACTH release. J Neuroendocrinol  vol. 15, (12) 1134-1143.  

John CD, Christian HC, Morris JF, Flower RJ, Solito E and Buckingham JC (2003). Kinase-dependent regulation of the secretion of thyrotrophin and luteinizing hormone by glucocorticoids and annexin 1 peptides. J Neuroendocrinol  vol. 15, (10) 946-957.  

de Coupade C, Solito E and Levine JD (2003). Dexamethasone enhances interaction of endogenous annexin 1 with L-selectin and triggers shedding of L-selectin in the monocytic cell line U-937. Br J Pharmacol  vol. 140, (1) 133-145.  

Buckingham JC, Solito E, John C, Tierney T, Taylor A, Flower R, Christian H and Morris J (2003). Annexin 1: a paracrine/juxtacrine mediator of glucorticoid action in the neuroendocrine system. Cell Biochem Funct  vol. 21, (3) 217-221.  

Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S and Perretti M (2003). A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J  vol. 17, (9) 1544-+.  

Croxtall JD, Gilroy DW, Solito E, Choudhury Q, Ward BJ, Buckingham JC and Flower RJ (2003). Attenuation of glucocorticoid functions in an Anx-A1-/- cell line. Biochem J  vol. 371, (Pt 3) 927-935.  

Solito E, Mulla A, Morris JF, Christian HC, Flower RJ and Buckingham JC (2003). Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase c, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. ENDOCRINOLOGY  vol. 144, (4) 1164-1174.  

FLOWER RJ, John C, Solito E, Morris J, Tierney T, Taylor A, Christian H and Buckingham JC (2003). Annexin 1: a paracrine/juxtacrine mediator of glucorticoid action in the neuroendocrine system. Cell Biochemistry and Function.  vol. 21, (3) 217-221.  

FLOWER RJ, Morris JF, Christian HC, Buckingham JC, Solito E and John CD (2003). Kinase-Dependent Regulation of the Secretion of Thyrotrophin and Luteinizing Hormone By Glucocorticoids and Annexin 1 Peptides. J Neuroendocrinol.  vol. 15, (10) 946-957.  

Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, Solito E and Serhan CN (2002). Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med  vol. 8, (11) 1296-1302.  

Perretti M, Ingegnoli F, Wheller SK, Blades MC, Solito E and Pitzalis C (2002). Annexin 1 modulates monocyte-endothelial cell interaction in vitro and cell migration in vivo in the human SCID mouse transplantation model. J Immunol  vol. 169, (4) 2085-2092.  

Mulla A, Buckingham JC and Solito E (2002). LPS acts via IL-6 and IL-1 to modulate the expression and phosphorylation of annexin 1 in cell lines derived from the putative microglia of the neuroendocrine system. BRIT J PHARMACOL  vol. 135,  

Solito E, Mulla A and Buckingham JC (2002). Dexamethasone induces serine phosphorylation of annexin 1: Involvement of PKC and PI3-kinase. BRIT J PHARMACOL  vol. 135,  

Solito E, Mulla A, Flower RJ and Buckingham JC (2002). Lipocortin 1 (Annexin 1). Wiley Encyclopedia of Molecular Medicine  Wiley   

FLOWER RJ, Buckingham J, Christian H, Solito E, John C, Cover P and Morris J (2002). Annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland: roles of the N-terminal domain and protein kinase C. Endocrinology.  vol. 143, (8) 3060-3070.  

de Coupade C, Ajuebor MN, Russo-Marie F, Perretti M and Solito E (2001). Cytokine modulation of liver annexin 1 expression during experimental endotoxemia. AM J PATHOL  vol. 159, (4) 1435-1443.  

Kamal AM, Smith SF, De Silva Wijayasinghe M, Solito E and Corrigan CJ (2001). An annexin 1 (ANXA1)-derived peptide inhibits prototype antigen-driven human T cell Th1 and Th2 responses in vitro. Clin Exp Allergy  vol. 31, (7) 1116-1125.  

Perretti M, Getting SJ, Solito E, Murphy PM and Gao JL (2001). Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. AM J PATHOL  vol. 158, (6) 1969-1973.  

John CD, Solito E, Mulla A, Morris JF, Flower RJ and Buckingham JC (2001). Dexamethasone induces serine phosphorylation of annexin 1 in pituitary cells and suppresses ACTH release by a PKC-dependent mechanism. BRIT J PHARMACOL  vol. 133, U20-U20.  

Solito E, de Coupade C, Canaider S, Goulding NJ and Perretti M (2001). Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. BRIT J PHARMACOL  vol. 133, (2) 217-228.  

Solito E, Tissot M, Russo-Marie F and Marullo S (2000). Extracellular annexin-1 accelerates apoptosis of human polymorphonuclears neutrophils. MOL BIOL CELL  vol. 11, 462A-463A.  

D'Amico M, Di Filippo C, La M, Solito E, McLean PG, Flower RJ, Oliani SM and Perretti M (2000). Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment. FASEB J  vol. 14, (13) 1867-1869.  

Solito E, Romero IA, Marullo S, Russo-Marie F and Weksler BB (2000). Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the alpha 4 beta 1 integrin. J Immunol  vol. 165, (3) 1573-1581.  

Mulla A, Christian H, Morris J, Mendoza N, Solito E and Buckingham J (2000). Expression of annexins 1 and 5 in human pituitary tumours. J PHYSIOL-LONDON  vol. 525, 53P-54P.  

Solito E, Tissot M, Russo-Marie F and Marullo S (2000). Extracellular Annexin 1 induces apoptosis of human polymorphonuclear neutrophils. FASEB J  vol. 14, (8) A1357-A1357.  

Le Maire V, Solito E, Russo-Marie F, Hernvann A, Le Marechal H, Ekindjian OG and Aussel C (2000). System A neutral amino acid transporter regulation by interleukin-1beta in human osteoarthritic synovial cells: evidence for involvement of prostaglandin E(2) as a second messenger. J Cell Physiol  vol. 183, (1) 65-73.  

Canaider S, Solito E, de Coupade C, Flower RJ, Russo-Marie F, Goulding NJ and Perretti M (2000). Increased apoptosis in U937 cells over-expressing lipocortin 1 (annexin I). Life Sci  vol. 66, (18) PL265-PL270.  

Perretti M, Solito E, La M, Russo-Marie F, Marullo S, D'Amico M and Flower RJ (2000). Annexin 1 activates human neutrophils: A mechanism for its anti-inflammatory in vivo effect. FASEB J  vol. 14, (4) A8-A8.  

de Coupade C, Gillet R, Bennoun M, Briand P, Russo-Marie F and Solito E (2000). Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology  vol. 31, (2) 371-380.  

D'Amico M, Di Filippo C, Solito E, Flower RJ and Perretti M (2000). Lipocortin 1 inhibits myocardial infarct by reducing local neutrophil infiltration. BRIT J PHARMACOL  vol. 129, U56-U56.  

Gidon-Jeangirard C, Solito E, Hofmann A, Russo-Marie F, Freyssinet JM and Martínez MC (1999). Annexin V counteracts apoptosis while inducing Ca(2+) influx in human lymphocytic T cells. Biochem Biophys Res Commun  vol. 265, (3) 709-715.  

Young KA, Hirst WD, Solito E and Wilkin GP (1999). De novo expression of lipocortin-1 in reactive microglia and astrocytes in kainic acid lesioned rat cerebellum. Glia  vol. 26, (4) 333-343.  

Canaider S, Solito E, Goulding NJ, Flower RJ and Perretti M (1999). Increased apoptosis in cells overexpressing lipocortin 1. BRIT J PHARMACOL  vol. 126, U26-U26.  

John CD, Cover PO, Taylor AD, Morris JF, Flower RJ, Solito E and Buckingham JC (1999). Evidence from in vivo and in vitro studies that the inhibitory actions of lipocortin 1 on anterior pituitary function require amino acid residues 13-26. BRIT J PHARMACOL  vol. 126, U74-U74.  

Raguenes-Nicol C, Russo-Marie F, Domage G, Diab N, Solito E, Dray F, Mace JL and Streichenberger G (1999). Anti-inflammatory mechanism of alminoprofen: action on the phospholipid metabolism pathway. Biochem Pharmacol  vol. 57, (4) 433-443.  

Raugei G, Degl'Innocenti D, Chiarugi P, Solito E, Modesti A and Ramponi G (1999). Preferential accumulation of muscle type acylphosphatase in the nucleus during differentiation. Biochem Mol Biol Int  vol. 47, (1) 127-136.  

Lim LH, Solito E, Russo-Marie F, Flower RJ and Perretti M (1998). Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A  vol. 95, (24) 14535-14539.  

Solito E, Raguenes-Nicol C, de Coupade C, Bisagni-Faure A and Russo-Marie F (1998). U937 cells deprived of endogenous annexin 1 demonstrate an increased PLA2 activity. Br J Pharmacol  vol. 124, (8) 1675-1683.  

Solito E, de Coupade C, Parente L, Flower RJ and Russo-Marie F (1998). IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine  vol. 10, (7) 514-521.  

Solito E, de Coupade C, Parente L, Flower RJ and Russo-Marie F (1998). Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ  vol. 9, (4) 327-336.  

Dubois T, Mira JP, Feliers D, Solito E, Russo-Marie F and Oudinet JP (1998). Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration. Biochem J  vol. 330 ( Pt 3), (Pt 3) 1277-1282.  

Lim LHK, Getting SJ, Das AM, Solito E, Flower RJ and Perretti M (1997). Inhibition of neutrophil : endothelium interaction in murine post-capillary venules by lipocortin 1. BRIT J PHARMACOL  vol. 122, U54-U54.  

Voermans PH, Go KG, Horst GJT, Ruiters MHJ, Solito E and Parente L (1997). P-3-325 Steroid-induced expression of annexinin brain. Elsevier  Clinical Neurology and Neurosurgery  vol. 99, s145-s146.  

Voermans PH, Go KG, ter Horst GJ, Ruiters MHJ, Solito E and Parente L (1997). Expression of Annexin and Annexin-mRNA in Rat Brain Under Influence of Steroid Drugs. Brain Edema X  Springer Nature   

Voermans PH, Go KG, ter Horst GJ, Ruiters MH, Solito E and Parente L (1997). Expression of annexin and annexin-mRNA in rat brain under influence of steroid drugs. Acta Neurochir Suppl  vol. 70, 222-224.  

Cifone MG, Cironi L, Roncaioli P, Martinotti S, Toniato E, Cilenti L, Botti D, Solito E, Parente L and Santoni A (1996). Phospholipase A(2) activity and calpactin I levels in rat lymphokine-activated killer cells: Correlation with the cytotoxic activity. CELL IMMUNOL  vol. 170, (2) 274-282.  

Ambrosetti DC, Palla E, Mirtella A, Galeotti C, Solito E, Navarra P, Parente L and Melli M (1996). Synthetic alleles at position 121 define a functional domain of human interleukin-1 beta. Eur J Biochem  vol. 238, (2) 308-316.  

Voermans PH, Go KG, Horst GJ, Ruiters MH, Solito E and Parente L (1996). Induction of annexin-1 at transcriptional and post-transcriptional level in rat brain by methylprednisolone and the 21-aminosteroid U74389F. Mediators Inflamm  vol. 5, (5) 370-378.  

Parente L, Ambrosetti D, Palla E, Mirtella A, Galeotti CL, Solito E, Navarra P and Melli M (1995). A new functional binding site for interleukin-1beta? Elsevier  Pharmacological Research  vol. 31,  

Parente L and Solito E (1994). Association between glucocorticosteroids and lipocortin 1. Trends Pharmacol Sci  vol. 15, (10)  

Solito E, Nuti S and Parente L (1994). Dexamethasone-induced translocation of lipocortin (annexin) 1 to the cell membrane of U-937 cells. Br J Pharmacol  vol. 112, (2) 347-348.  

Go KG, Zuiderveen F, De Ley L, Ter Haar JG, Parente L, Solito E and Molenaar WM (1994). Effect of steroids on brain lipocortin immunoreactivity. Acta Neurochir Suppl (Wien)  vol. 60, 101-103.  

Go KG, Ter Haar JG, de Ley L, Zuiderveen F, Parente L, Solito E and Molenaar WM (1994). The effect of steroid treatment on lipocortin immunoreactivity of rat brain. Mediators Inflamm  vol. 3, (3) 177-180.  

GO KG, ZUIDERVEEN F, DELEY L, TERHAAR JG, PARENTE L, SOLITO E and MOLENAAR WM (1994). EFFECT OF STEROIDS ON BRAIN LIPOCORTIN IMMUNOREACTIVITY. ACTA NEUROCHIR  101-103.  

PARENTE L, NUTI S and SOLITO E (1994). DEXAMETHASONE INDUCES THE TRANSLOCATION OF LIPOCORTIN-1 TO THE MEMBRANE OF HUMAN MONOCYTIC U-937 CELLS. BRIT J PHARMACOL  vol. 111, P72-P72.  

SOLITO E, PALLA E, BENSI G, FASSINA G, MELLI M and PARENTE L (1994). IDENTIFICATION OF ACTIVE-SITES OF INTERLEUKIN-1-BETA BY LOOP SUBSTITUTION AND SITE-DIRECTED MUTAGENESIS. BRIT J PHARMACOL  vol. 111, P31-P31.  

De Caterina R, Sicari R, Giannessi D, Paggiaro PL, Paoletti P, Lazzerini G, Bernini W, Solito E and Parente L (1993). Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J Appl Physiol (1985)  vol. 75, (6) 2368-2375.  

Palla E, Bensi G, Solito E, Buonamassa DT, Fassina G, Raugei G, Spano F, Galeotti C, Mora M and Domenighini M (1993). Loop substitution as a tool to identify active sites of interleukin-1 beta. J Biol Chem  vol. 268, (18) 13486-13492.  

BECHERUCCI C, PERRETTI M, SOLITO E, GALEOTTI CL and PARENTE L (1993). CONCEIVABLE DIFFERENCE IN THE ANTIINFLAMMATORY MECHANISMS OF LIPOCORTIN-1 AND LIPOCORTIN-5. MEDIAT INFLAMM  vol. 2, (2) 109-113.  

Rubartelli A, Bajetto A, Bonifaci N, Di Blas E, Solito E and Sitia R (1993). A novel way to get out of the cell. Cytotechnology  vol. 11 Suppl 1, S37-S40.  

Solito E, De Caterina R, Giannessi D, Paggiaro PL, Sicari R and Parente L (1993). Studies on the induction of lipocortin-1 by glucocorticoids. Ann Ist Super Sanita  vol. 29, (3) 391-394.  

Becherucci C, Perretti M, Solito E, Galeotti CL and Parente L (1993). Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5. Mediators Inflamm  vol. 2, (2) 109-113.  

Parente L, Galeotti CL, Ghiara P, Melli M, Mugridge KG and Solito E (1992). Mechanisms of IL-1 different biological activities. Studies using IL-1 muteins and IL-1 receptor antibodies. Elsevier  Pharmacological Research  vol. 26,  

Parente L, Solito E, Giannessi P, Paggiari P, Sicari R and De Caterina R (1992). Inhibition of eicosanoid formation and lipocortin induction by glucocorticoids in human cell lines and in patients with inflammatory lung disease. Pharmacol Res  vol. 26 Suppl 2, 44-45.  

de Caterina R, Sicari R, Giannessi D, Paggiaro PL, Paoletti P, Lazzerini G, Bernini W, Solito E and Parente L (1992). Induction of synthesis of lipocortin-I and inhibition of eicosanoid production in inflammatory cells: Evidence for a cell selectivity in glucocorticoid action. Elsevier  Thrombosis Research  vol. 65,  

Solito E, Raugei G, Melli M and Parente L (1992). Glucocorticoid effect on lipocortin mRNA expression in U-937 cells. Pharmacol Res  vol. 25 Suppl 1, 13-14.  

Perretti M, Solito E and Parente L (1992). Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice. Agents Actions  vol. 35, (1-2) 71-78.  

Solito E, Raugei G, Melli M and Parente L (1991). Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FEBS Lett  vol. 291, (2) 238-244.  

SOLITO E, RAUGEI G, MELLI M and PARENTE L (1991). DEXAMETHASONE INDUCES THE EXPRESSION OF THE MESSENGER-RNA OF LIPOCORTIN-1 AND LIPOCORTIN-2 AND THE RELEASE OF LIPOCORTIN-1 AND LIPOCORTIN-5 IN DIFFERENTIATED, BUT NOT UNDIFFERENTIATED U-937 CELLS. FEBS LETT  vol. 291, (2) 238-244.  

Perretti M, Becherucci C, Mugridge KG, Solito E, Silvestri S and Parente L (1991). A novel anti-inflammatory peptide from human lipocortin 5. Br J Pharmacol  vol. 103, (2) 1327-1332.  

Solito E, Raugei G, Melli M and Parente L (1991). Effect of dexamethasone and phorbol myristate acetate on lipocortin 1, 2 and 5 mRNA and protein synthesis. Adv Prostaglandin Thromboxane Leukot Res  vol. 21A, 291-294.  

Boraschi D, Villa L, Ghiara P, Tagliabue A, Mengozzi M, Solito E, Parente L, Silvestri S, Van Damme J and Ghezzi P (1991). Mechanism of acute toxicity of IL-1 beta in mice. Eur Cytokine Netw  vol. 2, (1) 61-67.  

SOLITO E, RAUGEI G, MELLI M and PARENTE L (1991). EFFECT OF DEXAMETHASONE AND PHORBOL-MYRISTATE ACETATE ON LIPOCORTIN-1, LIPOCORTIN-2 AND LIPOCORTIN-5 MESSENGER-RNA AND PROTEIN-SYNTHESIS. ADV PROSTAG THROMB L  vol. 21, 291-294.  

Parente L, Mugridge KG, Perretti M and Solito E (1990). In vitro and in vivo activation of phospholipase A2 by interleukin-1. Elsevier  Pharmacological Research  vol. 22,  

Becherucci C, Solito E, Perretti M, Mugridge KG, Galeotti CL and Parente L (1990). Purification and biological activity of human lipocortin 2. Pharmacol Res  vol. 22 Suppl 1, 29-30.  

Parente L, Becherucci C, Perretti M, Solito E, Mugridge KG, Galeotti CL, Raugei G, Melli M and Sanso M (1990). Are the lipocortins the second messengers of the anti-inflammatory action of glucocorticoids? Prog Clin Biol Res  vol. 349, 55-68.  

Solito E and Parente L (1989). Modulation of phospholipase A2 activity in human fibroblasts. Br J Pharmacol  vol. 96, (3) 656-660.  

SOLITO E and PARENTE L (1988). ACTIVATION OF PHOSPHOLIPASE-A2 BY INTERLEUKIN-1 IN HUMAN-FIBROBLASTS. LYMPHOKINE RES  vol. 7, (3) 261-261.  

Solito E, Busoni P and Bini L (1985). [Relational perspective in a district service for the substance-dependent]. Minerva Psichiatr  vol. 26, (3) 267-269.